• Publications
  • Influence
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Tumor site–specific HPV prevalence was higher among studies from North America compared with Europe and Asia, and the high HPV16 prevalence and the lack of HPV18 in oropharyngeal compared with other HNSCCs may point to specific virus-tissue interactions. Expand
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
A meta‐analyses of HPV type distribution in invasive cervical cancer (ICC) and high‐grade squamous intraepithelial lesions (HSIL) identified a total of 14,595 and 7,094 cases, respectively, suggesting differences in type‐specific risks for progression. Expand
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
A majority of ICC was associated with HPV16 or 18 in all regions, but approximately a quarter of all ICC cases were associated with one of 16 other HPV types, their distribution varying by region. Expand
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
HPV appears to play an etiologic role in many cancers of the oropharynx and possibly a small subgroup of cancers of The most common HPV type in genital cancers (HPV16) was also the most common in these tumors. Expand
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.
Application of existing public health methods for infection prevention, such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on the future burden of cancer worldwide. Expand
Global burden of human papillomavirus and related diseases.
Cervical cancer is the third most common female malignancy and shows a strong association with level of development, rates being at least four-fold higher in countries defined within the low ranking of the Human Development Index (HDI) compared with those in the very high category. Expand
Global burden of cancers attributable to infections in 2012: a synthetic analysis.
A large potential exists for reducing the burden of cancer caused by infections, and population-based vaccination and screen-and-treat programmes should be made accessible and available. Expand
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta‐analysis
In conclusion, ∼40% of vulvar, 60% of vaginal and 80% of anal carcinoma may be avoided by prophylactic vaccines against HPV16/18, and this proportion would be similar for the corresponding high‐grade lesions of the vagina and anus, but higher for VIN2/3 than for vulvar carcinoma. Expand
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
A meta‐analysis of HPV type‐specific prevalence data published from 1990 to 2010 found that overall HPV prevalence increased significantly and the proportion of ICC associated with HPV16 and/or 18 (HPV16/18) was between 70 and 76% in all world regions except Asia. Expand
Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer
Genotyping may improve risk stratification of high‐risk (HR) human papillomavirus (HPV)‐positive women in cervical screening programs; however, prospective data comparing the natural history andExpand